Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual diet program aims to stop obesity in young leukemia patients

NCT ID NCT05963971

Recruiting now Prevention Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 6-month virtual nutrition education program (PEDALL) to prevent overweight and obesity in children and teens with acute lymphoblastic leukemia (ALL) during maintenance chemotherapy. The program is offered in English and Spanish to 376 participants aged 5-21. Researchers will track body mass index (BMI) changes and also look at how genetics and social factors affect results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
virtual nutrition education program
What this could lead to
If it works, this could help children with leukemia avoid unhealthy weight gain during treatment, improving their long-term health.
What could go wrong
This is a behavioral intervention, not a drug, so results depend on families sticking with the program. It is also early-stage and may not show a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia neoplasm Obesity obesity disorder Precursor Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LYMPHOBLASTIC LEUKEMIA OBESITY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.